These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 20087127

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus.
    Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, Jallo GI.
    J Neurosurg; 2005 Aug; 103(2 Suppl):131-6. PubMed ID: 16370278
    [Abstract] [Full Text] [Related]

  • 3. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
    Ritz R, Roser F, Morgalla M, Dietz K, Tatagiba M, Will BE.
    BMC Infect Dis; 2007 May 08; 7():38. PubMed ID: 17488498
    [Abstract] [Full Text] [Related]

  • 4. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts.
    Parker SL, Attenello FJ, Sciubba DM, Garces-Ambrossi GL, Ahn E, Weingart J, Carson B, Jallo GI.
    Childs Nerv Syst; 2009 Jan 08; 25(1):77-83; discussion 85. PubMed ID: 18985357
    [Abstract] [Full Text] [Related]

  • 5. Antibiotic-impregnated shunt systems versus standard shunt systems: a meta- and cost-savings analysis.
    Klimo P, Thompson CJ, Ragel BT, Boop FA.
    J Neurosurg Pediatr; 2011 Dec 08; 8(6):600-12. PubMed ID: 22132919
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters.
    Eymann R, Chehab S, Strowitzki M, Steudel WI, Kiefer M.
    J Neurosurg Pediatr; 2008 Jun 08; 1(6):444-50. PubMed ID: 18518694
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost analysis of antibiotic-impregnated catheters in the treatment of hydrocephalus in adult patients.
    Farber SH, Parker SL, Adogwa O, Rigamonti D, McGirt MJ.
    World Neurosurg; 2010 Jun 08; 74(4-5):528-31. PubMed ID: 21492607
    [Abstract] [Full Text] [Related]

  • 10. Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components.
    Sciubba DM, Lin LM, Woodworth GF, McGirt MJ, Carson B, Jallo GI.
    Neurosurg Focus; 2007 Apr 15; 22(4):E9. PubMed ID: 17613199
    [Abstract] [Full Text] [Related]

  • 11. Cost savings associated with antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus.
    Parker SL, McGirt MJ, Murphy JA, Megerian JT, Stout M, Engelhart L.
    World Neurosurg; 2015 Mar 15; 83(3):382-6. PubMed ID: 24933241
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Infection rate with application of an antibiotic-impregnated catheter for shunt implantation in children - a retrospective analysis.
    Eymann R, Steudel WI, Kiefer M.
    Klin Padiatr; 2009 Mar 15; 221(2):69-73. PubMed ID: 19263325
    [Abstract] [Full Text] [Related]

  • 14. Comparative effectiveness of antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus: analysis of 12,589 consecutive cases from 287 US hospital systems.
    Parker SL, McGirt MJ, Murphy JA, Megerian JT, Stout M, Engelhart L.
    J Neurosurg; 2015 Feb 15; 122(2):443-8. PubMed ID: 25415066
    [Abstract] [Full Text] [Related]

  • 15. Cerebrospinal shunt infection in patients receiving antibiotic-impregnated versus standard shunts.
    Parker SL, Anderson WN, Lilienfeld S, Megerian JT, McGirt MJ.
    J Neurosurg Pediatr; 2011 Sep 15; 8(3):259-65. PubMed ID: 21882917
    [Abstract] [Full Text] [Related]

  • 16. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
    Conen A, Walti LN, Merlo A, Fluckiger U, Battegay M, Trampuz A.
    Clin Infect Dis; 2008 Jul 01; 47(1):73-82. PubMed ID: 18484878
    [Abstract] [Full Text] [Related]

  • 17. Pediatric neurosurgical practice patterns designed to prevent cerebrospinal fluid shunt infection.
    Gruber TJ, Riemer S, Rozzelle CJ.
    Pediatr Neurosurg; 2009 Jul 01; 45(6):456-60. PubMed ID: 20110759
    [Abstract] [Full Text] [Related]

  • 18. Management of shunt infections: a multicenter pilot study.
    Kestle JR, Garton HJ, Whitehead WE, Drake JM, Kulkarni AV, Cochrane DD, Muszynski C, Walker ML.
    J Neurosurg; 2006 Sep 01; 105(3 Suppl):177-81. PubMed ID: 16970229
    [Abstract] [Full Text] [Related]

  • 19. Conservative management of patients with cerebrospinal fluid shunt infections.
    Brown EM, Edwards RJ, Pople IK.
    Neurosurgery; 2006 Apr 01; 58(4):657-65; discussion 657-65. PubMed ID: 16575329
    [Abstract] [Full Text] [Related]

  • 20. The impact of antibiotic-impregnated catheters on shunt infection in children and neonates.
    Hayhurst C, Cooke R, Williams D, Kandasamy J, O'Brien DF, Mallucci CL.
    Childs Nerv Syst; 2008 May 01; 24(5):557-62. PubMed ID: 17962953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.